- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer | ||
| Mo | FDA rejection of extended dosing interval is another piece of bad news for Regeneron's Eylea HD | ||
| 18.04. | Sanofi, Regeneron score their 7th indication for Dupixent with FDA nod to treat hives condition | ||
| 18.04. | RFK Jr.'s FDA staff cuts claimed key user fee negotiators, threatening renewal talks with pharma: Reuters | ||
| 18.04. | FDA moves to block biopharma employees from serving on advisory committees | ||
| 18.04. | Navigating Trump's tariffs for pharma | ||
| 18.04. | Fierce Pharma Asia-The latest on Trump's tariffs; Leqembi's EU approval; Kyowa Kirin's biologics plant | ||
| 17.04. | Ligand's Pelthos unit joins forces with Channel Therapeutics in merger centered on launch of molluscum gel Zelsuvmi | ||
| 17.04. | Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts | ||
| 17.04. | Recently departed CBER director warns FDA staff cuts could upend drug review timelines as early as next year: BMO | ||
| 17.04. | GSK kicks off Blenrep's market return with first myeloma combo nod in UK | ||
| 17.04. | TV drug ad spending continues upward climb, logging nearly 30% growth in Q1 | ||
| 17.04. | AstraZeneca's Alexion accused of extending Soliris monopoly through sham patents in new suit | ||
| 17.04. | RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance | ||
| 17.04. | Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant | ||
| 17.04. | Ipsen's liver disease drug Iqirvo off to promising launch in battle with Gilead's Livdelzi | ||
| 16.04. | RFK Jr. targets HHS' vaccine safety reporting system, pledges changes: Stat | ||
| 16.04. | CDC vaccine panel review indicates potential changes to COVID, HPV immunization policies | ||
| 16.04. | GSK scolded after complainant flags 'shocking error' in prescribing information | ||
| 16.04. | Trump throws pharma 'bread crumb' concession with call to end IRA pill penalty | ||
| 16.04. | With looming Trump tariffs, pharma companies demand changes to stay in EU | ||
| 16.04. | Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal | ||
| 15.04. | Apellis, AstraZeneca break down their FierceMadness 2025 Drug Ad Tournament success | ||
| 15.04. | As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations | ||
| 15.04. | BMS' growth driver Camzyos fails in heart disease trial, denting expansion opportunity |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
